Clinical Trials Directory

Trials / Unknown

UnknownNCT01841229

Effect of Ginseng on Glycemic Control

Effect of Ginseng on Glycemic Control: A Systematic Review and Meta-analysis of Controlled Trials to Provide Evidence-based Clinical Recommendations

Status
Unknown
Phase
Study type
Observational
Enrollment
770 (actual)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Ginseng (American ginseng, Asian ginseng, Korean ginseng etc) is expected to show positive hypoglycemic effects, including improvements in glycated blood proteins\[HbA1c\], fasting glucose, fasting insulin, and the homeostasis model assessment of insulin resistance \[HOMA-IR\]).

Detailed description

Ginseng has demonstrated to have significant hypoglycemic effect. Its major pharmacological component is considered to be ginsenosides. Several trials have been undertaken in diabetes some of which have demonstrated advantages in glycemic control in both diabetic as well as non diabetic individuals although clinical consistency of results is lacking.The lack of high quality data in this area to support diabetes recommendations represents an urgent call for stronger evidence. A systematic review and meta-analysis of controlled trials remains the "Gold Standard" of evidence for recommendations and clinical guidelines development. Therefore, investigators will conduct a systematic review and meta-analyses of controlled trials to assess the effect of ginseng on glycemic control.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2013-04-26
Last updated
2013-05-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01841229. Inclusion in this directory is not an endorsement.